Genprex has dosed the first subject in the Phase II expansion portion of its Acclaim-3 trial of the Reqorsa gene therapy ...

Engineering is ahead of schedule, with all bulk quantities in line with budget. Procurement is at 82% of total supply value ...

Lawmakers in both chambers Wednesday considered the future of the low-income health care program, set to expire if they don’t ...

A new terminal for passengers at Arnold Palmer Regional Airport is on track for completion by Christmas. Officials said ...

The U.S. subsidiary of Bologna-based IMA Group said Wednesday it wants to construct an additional 35,000 square feet of space in which to produce more freeze-drying equipment.

By August or September of this year, Petersen said he expects “basically half” of the company’s $8 billion in manufacturing ...

In the Phase I dose escalation portion, which evaluated the combination in participants with small cell lung cancer, the first patient treated attained partial remission.